(435) 292-5548
 Medicare News
Home  ›  Prescription Assistance  ›  Tezspire

Biologics · COPD & Asthma

Tezspire Assistance Programs & Grants

Assistance information last verified: August 2026

AltaMedicare is an independent Medicare agency in Alpine, Utah, founded by Bret Swope, a licensed Medicare agent. We provide educational, no-pressure help comparing Medicare Advantage, Medigap (Medicare Supplement), and Part D at no cost, serving the entire state of Utah. Call or text (435) 292-5548.

Manufacturer programs, charitable grants and Medicare routes for Tezspire (tezepelumab-ekko) — each checked on its official source.

Can I get help paying for Tezspire?

Probably, through the Amgen Safety Net Foundation — but Amgen does not publish the numbers, and this page will not invent them. The foundation's eligibility page refused automated access on the checked date, and Amgen's Tezspire pages publish no copay dollar figures. What is confirmed is that the program exists, that Tezspire is in it, and that the enrolment form is built to handle Medicare patients. Every applicable charitable fund was closed.

  • Amgen Safety Net Foundation: Amgen's own Tezspire page describes it as being for patients who "have a financial need and are uninsured, or their insurance plan excludes the Amgen medicine". Its income limits and Medicare rule could NOT be read — the eligibility page returned an access-denied error. Call before ruling yourself in or out.
  • The TEZSPIRE Together enrolment form asks patients to declare Medicare, Medicare Advantage, Medicare Part D or Medicare Supplement coverage, and requires a prescriber PTAN "if the patient has Medicare" — so the program plainly contemplates Medicare patients.
  • TEZSPIRE Together Co-Pay Program: commercial or private insurance only. Amgen publishes no dollar amounts on its access page, so none are reproduced here.
  • Alternate funding programs disqualify you: if your employer or plan requires you to apply to a manufacturer program as a condition of coverage, Amgen states you are not eligible.
  • Charitable grants: TotalAssist lists Tezspire on its Asthma fund and Asthma health equity fund, both closed ($1,200 guaranteed / $3,500 maximum). HealthWell's Asthma fund was closed. Good Days has no asthma fund. Tezspire is NOT on the COPD fund, though Nucala and Dupixent are.
  • No generic and no biosimilar; not a Medicare-negotiated drug for 2026, 2027 or 2028.

None of the 5 programs we checked for Tezspire were accepting new applications when verified in August 2026 — see the alternatives below.

About Tezspire (tezepelumab-ekko)

Tezspire is an injected biologic given as add-on maintenance treatment for severe asthma. It works further upstream than the other severe-asthma biologics on this site, which is why it is used in people whose asthma does not fit a single allergic or eosinophilic pattern. For assistance purposes the important thing is that it is an Amgen medicine: the program, the rules and the phone numbers are entirely separate from those covering Nucala or Xolair.

Approved uses

  • Add-on maintenance treatment of severe asthma in adults and adolescents — confirm the exact age range and criteria on your own prescription with your prescriber
  • Chronic rhinosinusitis with nasal polyps, where the label supports it — check with your prescriber which indication yours was written for

Manufacturer: Amgen (developed with AstraZeneca)

Why Tezspire can be expensive on Medicare

Tezspire is a brand-only biologic with no generic and no biosimilar — DailyMed labels exactly one tezepelumab product. Part D plans place it on a specialty tier, where you pay a percentage of the price rather than a flat copay, and almost always behind prior authorization. Coinsurance at that level tends to consume the annual out-of-pocket cap in the first months of the year rather than spreading across it.

Medicare coverage context

Tezspire is covered under Medicare Part D or a Medicare Advantage drug plan when you or a caregiver inject it at home, generally on a specialty tier with prior authorization. If your doses are given in a clinic, the billing route can differ, so ask your prescriber's office which benefit applies before planning around a figure. Tezspire is not a Medicare-negotiated drug: CMS's selected-drug and Maximum Fair Price file has no Tezspire or tezepelumab row for 2026, 2027 or 2028 — worth checking rather than assuming, since Xolair, another severe-asthma biologic, was selected for 2028. Part D out-of-pocket costs are capped at $2,100 in 2026, and the Medicare Prescription Payment Plan can spread what you owe across the year, which for a specialty-tier biologic is often the practical difference between manageable and not.

Check typical Part D coverage · Estimate your drug costs · Compare Part D drug plans

Tezspire assistance options at a glance

Every program we checked, what kind of help it is, whether people with Medicare can use it, and its status when we verified it. A medication being listed by a program is not the same as the program accepting applications.

About the income limits below: Income limits can differ between assistance programs even when both describe their eligibility as the same percentage of the federal poverty level. The dollar limits shown here come from each program's own published income table, and each program decides which year's poverty guidelines that table is built from and when it takes effect. Treat the figures as belonging to the program they are listed under — they are not interchangeable, and only the program can tell you which table it is applying to your application today.

Tezspire assistance programs compared
ProgramType of helpPeople with MedicareStatus (August 2026)
Amgen Safety Net Foundation (TEZSPIRE Together Patient Assistance Program) Manufacturer patient assistance not stated Check current availability
TEZSPIRE Together Co-Pay Program Commercial copay / savings card not eligible Check current availability
TotalAssist — Asthma funds Charitable grant may apply Closed to new applicants
HealthWell Foundation — Asthma fund Charitable grant may apply Closed to new applicants
Good Days — no applicable fund Charitable grant not stated No program found
Medicare Extra Help (Part D Low-Income Subsidy) Government program may apply Accepting applications

Manufacturer programs from Amgen (developed with AstraZeneca)

A patient assistance program (free or low-cost drug by income) is not the same as a copay card (a commercial discount that usually excludes Medicare). Both are listed so you can see which one applies to you.

Manufacturer patient assistance

Amgen Safety Net Foundation (TEZSPIRE Together Patient Assistance Program)

Amgen Safety Net Foundation, a nonprofit sponsored by Amgen

Check current availability Medicare: not stated

Status: The program exists and covers Tezspire — Amgen's own access page says so — but its current eligibility terms could not be confirmed on August 26, 2026, because amgensafetynetfoundation.com/eligibility returned an HTTP 403 access-denied response to every automated request. The income limits and the specific Medicare rule are therefore unverified and are not reproduced here from third-party sources.

Amgen's charitable foundation has supplied Amgen medicines at no cost since 2001 and Tezspire is among them. What could not be established is who currently qualifies — so the instruction here is to phone rather than to read a figure off this page. Amgen also warns that third parties charging a fee for enrolment help are not the foundation: its assistance is free.

If you have Medicare: The foundation's published Medicare rule could not be read, and this project does not borrow one from another manufacturer. Two things are on record and worth using. First, Amgen describes the foundation as serving people who are "uninsured, or their insurance plan excludes the Amgen medicine" — wording that turns on whether your plan covers Tezspire rather than on whether you have Medicare. Second, the TEZSPIRE Together enrolment form asks the patient to declare Medicare, Medicare Advantage, Medicare Part D or Medicare Supplement coverage and requires the prescriber's PTAN "if the patient has Medicare", which is not something a program builds unless Medicare patients are expected. Call and ask directly: whether Medicare Part D enrollees may apply, what the income limit is, and whether Extra Help affects eligibility.

What it can cover: Amgen medicines, including Tezspire, at no cost to approved patients.

Who may qualify

  • Financial need, and either no insurance or an insurance plan that excludes the Amgen medicine (Amgen's own description)
  • Not enrolled through an alternate funding program — Amgen states patients whose insurance plan or employer participates in one requiring an application to a manufacturer program are not eligible
  • Residence in the United States or its territories
  • Current income limits and the specific Medicare rule: UNVERIFIED — the foundation's eligibility page could not be read on the checked date

What the application asks for

  • Household income including wages, Social Security, Social Security disability, unemployment and pensions — the enrolment form asks for all of these
  • Your insurance details, including Medicare, Medicare Advantage, Part D or Medicare Supplement coverage if you have them
  • Your prescriber's Tax ID and Provider Transaction Access Number (PTAN), which the form requires if you have Medicare

How to apply

Call TEZSPIRE Together on 888-897-7473 (888-TZSPIRE), Monday–Friday 8am–8pm ET, or Amgen SupportPlus on (866) 264-2778. Your prescriber's office completes part of the enrolment form, including the PTAN if you have Medicare. Because the published terms could not be verified, a phone call is the reliable route for this medication.

TEZSPIRE financial support → 888-897-7473

Commercial copay / savings card

TEZSPIRE Together Co-Pay Program

Amgen

Check current availability Medicare: not eligible

Status: Active for commercially insured patients on August 26, 2026, but its dollar terms could not be confirmed: Amgen's own access page states only that "Eligibility criteria and program maximums apply" and refers readers to the Tezspire Together terms and conditions. Figures for this card circulate on third-party sites; none were confirmed at an Amgen source, so none are published here.

A commercial copay offer. Recorded so Medicare readers can rule it out immediately and move to the foundation, and so anyone moving from commercial insurance onto Medicare knows their Tezspire support changes at that moment — which is one of the most common ways people are caught out.

If you have Medicare: Manufacturer copay cards are closed to Medicare across the board — federal anti-kickback rules prevent their use with Part D, Medicare Advantage drug coverage, Medicaid, TRICARE or VA benefits. Amgen describes this program as being for patients with commercial or private insurance. That general rule is why this card is recorded as excluded even though its specific dollar terms could not be read.

What it can cover: Part of the commercial copay or coinsurance for Tezspire. Not applicable to Medicare cost-sharing.

Who may qualify

  • Commercial or private insurance that covers Tezspire
  • Not enrolled in Medicare, Medicaid or another government prescription program
  • Current dollar terms unconfirmed — check the official terms and conditions before relying on a figure

How to apply

Commercially insured patients enrol at copay.tezspiretogether.com or by calling 888-897-7473. Medicare beneficiaries should call the same number and ask about the Amgen Safety Net Foundation instead.

TEZSPIRE Together Co-Pay Program → 888-897-7473

Charitable grants for Tezspire

Tezspire has a narrower charitable footprint than the other severe-asthma biologics on this site, and the difference is worth knowing if you have been switched between them. TotalAssist lists Tezspire on its Asthma fund and Asthma health equity fund — each $1,200 guaranteed up to $3,500, both closed on August 26, 2026 — but not on its COPD fund, where Nucala and Dupixent both appear. HealthWell's Asthma fund was closed and it runs no severe- or eosinophilic-asthma fund at all; Good Days has no asthma fund. With the Amgen foundation's terms unverified and every fund shut, the routes you can act on today are the phone call to Amgen, Extra Help, and the Medicare Prescription Payment Plan. Set alerts on TotalAssist and HealthWell so a reopening does not pass you by.

Charitable grant

TotalAssist — Asthma funds

Patient Advocate Foundation · Asthma · Asthma health equity

Closed to new applicants Medicare: may apply

Status: Both applicable funds were closed to new applicants on August 26, 2026, each with a $1,200 guaranteed and $3,500 maximum award. TotalAssist has no waitlist, so the notification sign-up is what gets you in.

"Tezspire (Tezepelumab-Ekko)" is named on the Asthma approved-medication list. Worth noting what is absent: Tezspire is not on the COPD fund, although Nucala and Dupixent are — so if you have been moved between biologics, your fund eligibility may have moved too.

If you have Medicare: These funds require government-insured coverage — Medicare, Medicaid or TRICARE — that covers your qualifying expenses. Medicare beneficiaries are eligible when a fund is open, and unlike the Amgen foundation these funds publish their rules plainly, which is a reason to work them in parallel rather than after.

What it can cover: When open: $1,200 guaranteed award and up to $3,500 maximum for medication copays, coinsurance, deductibles and health-insurance premiums. One grant per condition.

Who may qualify

  • Confirmed asthma diagnosis, in treatment, starting within 60 days, or treated in the past 6 months
  • Government-insured coverage (Medicare, Medicaid or TRICARE) that covers your qualifying expenses
  • Household income at or below 500% of the federal poverty level, adjusted for your regional cost-of-living index
  • Confirmed diagnosis matching the fund, and in treatment (or starting within 60 days, or treated in the past 6 months)
  • Legal U.S. resident receiving treatment in the U.S. or a U.S. territory
  • The health-equity fund additionally requires a home zip code in a designated social-vulnerability county

What the application asks for

  • Contact information and Social Security number (or alien number)
  • Annual household income (for pre-screening; proof of income due within 30 days of approval)
  • Health insurance carrier, plan type, policy ID and group number; Medicare supplement or secondary insurance if you have one
  • Copay or coinsurance amounts
  • Your provider's name and contact information, diagnosis (exact date if within 6 months), prescribed medications and treatment plan

How to apply

Sign up for fund notifications (text, email or automated call) at totalassist.org/notify. When a fund opens: You (the patient) apply online — it takes about 15 minutes and you learn immediately whether you are approved — or call 866-512-3861, Monday–Friday 8:30am–5:30pm ET. Patient Advocate Foundation verifies your diagnosis and treatment plan directly with your provider and verifies income automatically; you have 30 days after approval to provide proof of income.

Get notified when a TotalAssist fund opens → 866-512-3861

Charitable grant

HealthWell Foundation — Asthma fund

HealthWell Foundation · Asthma

Closed to new applicants Medicare: may apply

Status: Closed on August 26, 2026. HealthWell runs no severe-asthma or eosinophilic-asthma fund, so there is no narrower fund to fall back on.

One applicable fund, closed when we checked. HealthWell says replenished funds reopen as quickly as possible and offers real-time alerts, which is the practical move while the Amgen route stays unverified.

If you have Medicare: HealthWell accepts Medicare beneficiaries for the diseases it covers. Its Asthma fund is the only one that could apply to Tezspire, and it was closed.

What it can cover: When open: copays, coinsurance, deductibles and health-insurance premiums for asthma.

Who may qualify

  • A confirmed asthma diagnosis, verified by your prescriber
  • Some form of health insurance (Medicare qualifies) that covers part of the cost of the drug — discount cards do not count
  • Social Security number (used to prevent duplicate applications)
  • Diagnosis verified by a physician's, nurse practitioner's or physician assistant's signature
  • Treatment in the United States

What the application asks for

  • Some form of health insurance (Medicare qualifies) that covers part of the cost of the drug — discount cards do not count
  • Social Security number (used to prevent duplicate applications)
  • Diagnosis verified by a physician's, nurse practitioner's or physician assistant's signature
  • Treatment in the United States

How to apply

When a fund is open, apply online or by phone; your provider verifies the diagnosis by signature. When a fund is closed, sign up for that fund's real-time alerts — HealthWell says replenished funds reopen "as quickly as possible."

HealthWell disease funds and alerts → (800) 675-8416

Charitable grant

Good Days — no applicable fund

Good Days

No program found Medicare: not stated

Status: Good Days' published disease list on August 26, 2026 contained 57 programs and none of them was asthma.

An honest negative, checked so you do not spend time on a third foundation that has no fund for you.

If you have Medicare: Good Days accepts Medicare beneficiaries for the diseases it covers, but it covers no diagnosis that applies to Tezspire.

How to apply

Not applicable today. The diseases-covered page shows every fund Good Days runs.

Good Days diseases covered →

How to apply for Tezspire assistance

  1. Step 1 — Find the applicable assistance program

    For Tezspire on Medicare in August 2026, the order is shaped by what can be checked today versus what needs a phone call:

    • Call TEZSPIRE Together on 888-897-7473 and ask about the Amgen Safety Net Foundation. Its terms are not readable online, so the call is the only way to a current answer.
    • Limited income and resources → Medicare Extra Help through Social Security, which you can apply for today without waiting on Amgen.
    • Asthma diagnosis → set alerts on the TotalAssist and HealthWell asthma funds (all closed when checked).
    • Enrol in the Medicare Prescription Payment Plan if a specialty-tier bill in January is the problem.
    • Commercial insurance instead of Medicare → the TEZSPIRE Together Co-Pay Program, which Medicare enrollees cannot use.

  2. Step 2 — Check whether applications are currently open

    One manufacturer program whose terms are unverified, and three charitable funds that were closed.

    • Amgen Safety Net Foundation: the eligibility page is the official source; it refused automated access on the checked date, so call to confirm the program is accepting applications and what the limits are.
    • TotalAssist: the Asthma and Asthma health equity fund pages show "Open" or "Closed" and the current award amounts.
    • HealthWell: the disease-funds list shows the Asthma fund and its status.

  3. Step 3 — Check eligibility

    Two of these publish their rules; the manufacturer program does not:

    • Amgen Safety Net Foundation: UNVERIFIED income limits. Ask three specific questions — may Medicare Part D enrollees apply, what is the current income limit, and does Extra Help enrolment affect eligibility.
    • One Amgen rule that IS published: if your employer or health plan requires you to apply to a manufacturer assistance program as a condition of coverage — an "alternate funding program" — you are not eligible.
    • TotalAssist (when open): government insurance covering Tezspire; income at or below 500% FPL adjusted for your regional cost-of-living index; a confirmed asthma diagnosis in treatment.
    • HealthWell (when open): insurance that covers part of the drug's cost, a prescriber-verified asthma diagnosis, and treatment in the United States.
    • Extra Help: income below about $23,940 a year for one person or $32,460 for a couple, and countable resources limited to $18,090 or $36,100 in 2026.

  4. Step 4 — Gather your information

    Amgen's enrolment form asks for one item most programs do not:

    • Your prescriber's Tax ID and Provider Transaction Access Number (PTAN). The form requires the PTAN if you have Medicare, and your prescriber's office supplies it — ask for it early, because chasing it is a common delay.
    • Household income including wages, Social Security, Social Security disability, unemployment and pensions.
    • Medicare card and your Part D or Medicare Advantage drug-plan card, plus any Medicare Supplement or secondary coverage.
    • Your asthma diagnosis and its date. TotalAssist needs the exact date if it was within the past 6 months.
    • Whether you inject at home or receive doses in a clinic, since that can change which Medicare benefit pays.

  5. Step 5 — Complete the application

    Who fills out what:

    • Amgen Safety Net Foundation: you complete the patient sections; your prescriber's office completes the provider sections including the PTAN. TEZSPIRE Together on 888-897-7473 can walk both of you through it.
    • Extra Help: you (or someone helping you) apply free through Social Security — online, by phone on 1-800-772-1213, or at an office. There is never a fee.
    • TotalAssist (when open): you apply online in about 15 minutes or by phone on 866-512-3861.
    • HealthWell (when open): apply online or by phone; your provider verifies the diagnosis by signature.

  6. Step 6 — Submit and wait for a determination

    What to expect:

    • Amgen Safety Net Foundation: unverified timeframe. Ask when you call, and ask what happens to your doses while the application is pending.
    • Extra Help: Social Security notifies you by mail; your Part D plan then applies the lower copays.
    • TotalAssist (when open): an immediate online decision, with proof of income due within 30 days of approval.
    • HealthWell (when open): a decision once your provider returns the diagnosis verification.

  7. Step 7 — If the program is closed or you don't qualify

    For a specialty biologic with no generic, the Medicare-side tools carry the weight:

    • Enrol in the Medicare Prescription Payment Plan. It does not lower the total, but it stops a specialty-tier bill landing all at once in January.
    • Apply for Extra Help even if you assume you earn too much — the limits are higher than most people expect.
    • Ask your prescriber's office about a formulary or tier exception if coinsurance is the obstacle.
    • If you were switched to Tezspire from another biologic, check your charitable fund eligibility again — Tezspire is not on the COPD fund even though Nucala and Dupixent are.
    • Do not wait for a generic — DailyMed labels exactly one tezepelumab product, and no biosimilar exists.
    • Call AltaMedicare — we will work through every route above with you, free, including making the Amgen call with you.

What you'll need

Only items the programs above actually ask for. Gather these before you start.

  • Medicare card and your Part D or Medicare Advantage drug-plan card — plan name, member ID and group number
  • Prescription details — medication name, strength and dose; prescriber name, office phone and address
  • Diagnosis and date of diagnosis — TotalAssist needs the exact date if diagnosed within the past 6 months
  • Household size and annual household income — and proof — tax return, Social Security or pension statements, or pay stubs
  • Your prescriber's Provider Transaction Access Number (PTAN) and Tax ID — Amgen's enrolment form requires the PTAN if the patient has Medicare — ask the prescriber's office for it early
  • Whether you inject at home or receive doses in a clinic — this can change which Medicare benefit pays
  • A note of the questions to ask Amgen — Medicare eligibility, the current income limit, and whether Extra Help affects it — none of these are published

If assistance is unavailable

A closed fund or a denial is not the end of the road. Check these next:

  1. Enrol in the Medicare Prescription Payment Plan. For a specialty-tier biologic this is often the most useful single step — it spreads what you owe across the year instead of front-loading it. Medicare.gov
  2. There is no generic or biosimilar to switch to — DailyMed labels exactly one tezepelumab product — so a formulary or tier exception through your plan is the alternative worth raising with your prescriber.
  3. Sign up for TotalAssist fund notifications so you hear the moment a Tezspire fund reopens — there is no waitlist or queue, so speed matters. TotalAssist notifications
  4. Sign up for HealthWell fund alerts for the same reason; HealthWell says closed funds reopen as funding is replenished. HealthWell disease funds
  5. Check Medicare Extra Help — it does not depend on a fund balance and lowers the cost of every covered drug, not just this one. Medicare Extra Help explained
  6. Ask your doctor's office — many practices have staff who handle assistance applications routinely and can request a formulary exception or a lower-cost alternative.
  7. Use the Medicare Prescription Payment Plan to spread this year's out-of-pocket costs across monthly payments (it does not lower the total). Medicare.gov
  8. Compare Part D and Medicare Advantage drug plans during the fall enrollment period — the tier and cost-sharing for Tezspire differ from plan to plan. Compare Part D plan options

Could Medicare Extra Help reduce your Tezspire costs?

Extra Help is not a grant for Tezspire. It is a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription — so it is worth checking even when a charitable fund is closed, because it does not depend on fund balances.

Extra Help matters more than usual for Tezspire, because it is the one route on this page whose rules are fully published and immediately checkable. It lowers cost-sharing on every covered drug you take, and with full Extra Help a covered brand-name drug costs about $12.65 in 2026 — a very different number from specialty-tier coinsurance on a biologic. Whether Extra Help affects Amgen Safety Net Foundation eligibility is one of the questions this page could not answer, so ask it when you call; manufacturers differ, and Amgen's answer is not published.

In 2026, people with full Extra Help generally pay no more than $12.65 for a covered brand-name drug. Income must be below about $23,940 a year for one person ($32,460 for a couple) and countable resources under $18,090 ($36,100 for a couple). Apply free through Social Security — online, by phone at 1-800-772-1213, or in person — and never pay anyone to apply for you.

Extra Help explained · Medicare Savings Programs · Estimate your drug costs · Free prescription cost review

Government program

Medicare Extra Help (Part D Low-Income Subsidy)

Medicare / Social Security Administration

Accepting applications Medicare: may apply

Status: Year-round federal program (figures for 2026)

Not a grant for one drug — a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription.

If you have Medicare: For people with Medicare Part D or a Medicare Advantage drug plan who have limited income and resources.

What it can cover: Part D premium and deductible (often to $0) and reduced copays — generally no more than $12.65 for a covered brand-name drug in 2026 with full Extra Help.

Who may qualify

  • Income below 150% of the federal poverty level — about $23,940 a year for one person or $32,460 for a married couple in 2026.
  • Countable resources (savings, investments — not your home or car) limited to $18,090 for an individual or $36,100 for a married couple living together in 2026 (Medicare.gov figures, which include a burial-expense allowance).
  • Automatic if you have Medicaid, Supplemental Security Income (SSI), or a Medicare Savings Program.

What the application asks for

  • Social Security number and Medicare number
  • Income (Social Security, pensions, wages) for you and a spouse you live with
  • Value of savings, investments and other countable resources

How to apply

You (or someone helping you) apply free through Social Security — online, by phone, or at a Social Security office. There is never a fee to apply.

Apply for Extra Help at SSA.gov → 1-800-772-1213

Key terms on this page

Patient assistance program (PAP)
A manufacturer program that provides its medication free or at low cost to people who meet income and insurance rules. Many PAPs accept Medicare Part D enrollees; each sets its own criteria.
Copay card / savings card
A manufacturer discount for commercially insured patients. Federal anti-kickback rules mean these cards generally cannot be used with Medicare, Medicaid or other government insurance.
Charitable copay grant
Money from a nonprofit foundation (for example HealthWell or Patient Advocate Foundation) that pays eligible copays or coinsurance for a specific diagnosis. A drug can be listed while the fund is closed to new applicants.
Federal poverty level (FPL)
A federal income measure that assistance programs use as a yardstick — "300% of FPL", "500% of FPL". The percentage is a rule, but the dollar figure behind it comes from a table each program publishes itself, built on a chosen year of the HHS poverty guidelines. Two programs can quote the same percentage in the same year and still list different dollar limits; compare each program against its own table, not against another program.
Medicare Extra Help
The Part D Low-Income Subsidy: a Medicare program that lowers or eliminates Part D premiums, deductibles and copays for beneficiaries with limited income and resources. You apply through Social Security.
Maximum Fair Price (MFP)
The price Medicare negotiated for a selected drug under the Medicare Drug Price Negotiation Program. It applies to Part D plans, not to the pharmacy cash price, and it lowers what plans and enrollees pay for that drug.

Related medication assistance guides

Nucala Assistance & Grants mepolizumab Xolair Assistance & Grants omalizumab Dupixent Assistance & Grants dupilumab Breo Ellipta Assistance & Grants fluticasone furoate / vilanterol All prescription assistance Directory & program finder
Common Questions

Tezspire assistance FAQ

Does Medicare cover Tezspire?
Yes — Medicare Part D and Medicare Advantage drug plans generally cover Tezspire when you or a caregiver inject it at home, usually on a specialty tier with prior authorization. If your doses are given in a clinic, the billing route can differ, so ask your prescriber's office which benefit applies. Part D out-of-pocket costs are capped at $2,100 in 2026, and the Medicare Prescription Payment Plan can spread that across the year.
Is there a Tezspire patient assistance program for people on Medicare?
Amgen runs the Amgen Safety Net Foundation and Tezspire is covered by it, but we could not confirm its current Medicare rule or income limits — the foundation's eligibility page returned an access-denied error to every automated request on August 26, 2026. Rather than repeat figures from third-party sites, this page records the gap. Two confirmed clues are encouraging: Amgen describes the foundation as serving people whose "insurance plan excludes the Amgen medicine", and the enrolment form requires a prescriber PTAN "if the patient has Medicare". Call TEZSPIRE Together on 888-897-7473 and ask directly.
Why does this page not give a dollar amount for the Tezspire copay card?
Because Amgen does not publish one on its own access page — it states that "Eligibility criteria and program maximums apply" and refers readers to the Tezspire Together terms and conditions. Dollar figures for this card do circulate on third-party sites, but none of them could be confirmed at an Amgen source, and this project does not publish an assistance figure it has not seen at the source. In any case the card excludes Medicare, so for most readers of this page the number would not change anything.
How does Tezspire assistance differ from Nucala or Xolair?
Completely, and that surprises people who switch between them. All three are severe-asthma biologics, but Nucala is a GSK medicine assisted by the GSK Patient Access Programs Foundation, Xolair is a Genentech medicine assisted by the Genentech Patient Foundation with its distinctive 7.5%-of-income test, and Tezspire is an Amgen medicine assisted by the Amgen Safety Net Foundation. Different applications, different income rules, different phone numbers, and different charitable fund eligibility — Tezspire is not on the COPD fund that lists Nucala. If your biologic changes, start the assistance question over.
Is there a generic or biosimilar for Tezspire?
No. DailyMed lists exactly one labelled tezepelumab product. There is no generic and no biosimilar, so there is no lower-tier version to ask your prescriber about. That is part of why the specialty-tier coinsurance is difficult, and why Extra Help and the Medicare Prescription Payment Plan carry so much of the weight here.
Is Tezspire part of Medicare drug price negotiation?
No. CMS's selected-drug and Maximum Fair Price file has no Tezspire or tezepelumab row for initial price applicability year 2026, 2027 or 2028. This is worth checking rather than assuming, because Xolair — another severe-asthma biologic — was selected for 2028. Your Tezspire cost is set by your plan's specialty-tier coinsurance. See all prescription assistance options.

Sources

Related resources

Assistance information last verified August 2026. Program details — fund status, eligibility, prices, phone numbers — change often; confirm with each program before applying. AltaMedicare does not administer, fund or approve any assistance program. Not medical advice.

Having trouble figuring out your prescription costs?

Bret can help you understand your Medicare prescription coverage and where to look for Tezspire assistance — free, no pressure. We don't award grants or decide eligibility; the programs above do. We help you find and apply to the right ones.

Text Bret About Tezspire Call (435) 292-5548